| Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer B Tran, S Kopetz, J Tie, P Gibbs, ZQ Jiang, CH Lieu, A Agarwal, DM Maru, ... Cancer 117 (20), 4623-4632, 2011 | 861 | 2011 |
| Molecular biomarkers for the evaluation of colorectal cancer: guideline from the American Society for Clinical Pathology, College of American Pathologists, Association for … AR Sepulveda, SR Hamilton, CJ Allegra, W Grody, AM Cushman-Vokoun, ... American journal of clinical pathology 147 (3), 221-260, 2017 | 701 | 2017 |
| Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with … S Kopetz, PM Hoff, JS Morris, RA Wolff, C Eng, KY Glover, R Adinin, ... Journal of clinical oncology 28 (3), 453-459, 2010 | 546 | 2010 |
| Randomized trial of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (SWOG S1406) S Kopetz, KA Guthrie, VK Morris, HJ Lenz, AM Magliocco, D Maru, Y Yan, ... Journal of Clinical Oncology 39 (4), 285-294, 2021 | 467* | 2021 |
| Neuroendocrine tumors, version 1.2015 MH Kulke, MH Shah, AB Benson, E Bergsland, JD Berlin, LS Blaszkowsky, ... Journal of the National Comprehensive Cancer Network 13 (1), 78-108, 2015 | 417 | 2015 |
| Neuroendocrine and adrenal tumors, version 2.2021, NCCN clinical practice guidelines in oncology MH Shah, WS Goldner, AB Benson, E Bergsland, LS Blaszkowsky, ... Journal of the National Comprehensive Cancer Network 19 (7), 839-868, 2021 | 398 | 2021 |
| The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection SG Patel, JJ Karlitz, T Yen, CH Lieu, CR Boland The lancet Gastroenterology & hepatology 7 (3), 262-274, 2022 | 392 | 2022 |
| Beyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesis C Lieu, J Heymach, M Overman, H Tran, S Kopetz Clinical cancer research 17 (19), 6130-6139, 2011 | 358 | 2011 |
| NCCN guidelines insights: neuroendocrine and adrenal tumors, version 2.2018 MH Shah, WS Goldner, TR Halfdanarson, E Bergsland, JD Berlin, ... Journal of the National Comprehensive Cancer Network 16 (6), 693-702, 2018 | 352 | 2018 |
| ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper A Dasari, VK Morris, CJ Allegra, C Atreya, AB Benson III, P Boland, ... Nature reviews Clinical oncology 17 (12), 757-770, 2020 | 300 | 2020 |
| Treatment of metastatic colorectal cancer: ASCO guideline VK Morris, EB Kennedy, NN Baxter, AB Benson III, A Cercek, M Cho, ... Journal of Clinical Oncology 41 (3), 678-700, 2023 | 275 | 2023 |
| Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients IG Serebriiskii, C Connelly, G Frampton, J Newberg, M Cooke, V Miller, ... Nature communications 10 (1), 3722, 2019 | 199 | 2019 |
| Characteristics of early-onset vs late-onset colorectal cancer: a review R Collaborative, AM Zaborowski, A Abdile, M Adamina, F Aigner, ... JAMA surgery 156 (9), 865-874, 2021 | 198 | 2021 |
| Adjuvant therapy for stage II colon cancer: ASCO guideline update NN Baxter, EB Kennedy, E Bergsland, J Berlin, TJ George, S Gill, PJ Gold, ... Journal of Clinical Oncology 40 (8), 892-910, 2022 | 192 | 2022 |
| Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer ZY Chen, K Raghav, CH Lieu, ZQ Jiang, C Eng, JN Vauthey, GJ Chang, ... British journal of cancer 112 (6), 1088-1097, 2015 | 185 | 2015 |
| Association of age with survival in patients with metastatic colorectal cancer: analysis from the ARCAD Clinical Trials Program CH Lieu, LA Renfro, A De Gramont, JP Meyers, TS Maughan, ... Journal of Clinical Oncology 32 (27), 2975-2982, 2014 | 173 | 2014 |
| Somatic genomic testing in patients with metastatic or advanced cancer: ASCO provisional clinical opinion D Chakravarty, A Johnson, J Sklar, NI Lindeman, K Moore, S Ganesan, ... Journal of Clinical Oncology 40 (11), 1231-1258, 2022 | 172 | 2022 |
| Comprehensive genomic landscapes in early and later onset colorectal cancer CH Lieu, EA Golemis, IG Serebriiskii, J Newberg, A Hemmerich, ... Clinical cancer research 25 (19), 5852-5858, 2019 | 163 | 2019 |
| Targeting the WNT signaling pathway in cancer therapeutics D Tai, K Wells, J Arcaroli, C Vanderbilt, DL Aisner, WA Messersmith, ... The oncologist 20 (10), 1189-1198, 2015 | 157 | 2015 |
| Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts A Capasso, J Lang, TM Pitts, KR Jordan, CH Lieu, SL Davis, JR Diamond, ... Journal for immunotherapy of cancer 7, 1-16, 2019 | 146 | 2019 |
